⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Laboratorios Silanes and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Laboratorios Silanes
↗Mexico City, Mexico
Laboratorios Silanes is a leading, family-owned Mexican pharmaceutical company founded in 1943. The company focuses on the development, manufacturing, and commercialization of innovative medicines, with a strong historical emphasis on diabetes, cardiovascular health, analgesics, and antivenoms.
Silanes has established a significant global presence, exporting products to nearly 20 countries. It is recognized for its R&D capabilities, particularly in biotechnology through its institution, Bioclon, and is one of the few Latin American companies to have received FDA approval for its products in the United States.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Branded Generics, Biotechnology, Antivenoms
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$25M-$50M
Founded:1943
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Biologics, Antitoxin, Fab fragment
Active Trials:56
Trial Phases:-
FDA Approvals:1
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Bioclon
Key Partnerships:Hanmi Pharm. Co. (exporting treatments for dyslipidemia and hypertension)
COMPETITION
Position:Leader
LEADERSHIP
Key Executives:
Antonio López de Silanes - Founder (Historical)
LINKS
Website:silanes.com.mx
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Laboratorios Silanes. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.